Class IIOngoingD-0037-2027
Drug recall · October 14, 2026
Apothecary NAD+ Injection 200 mg/mL recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Apothecary NAD+ Injection 200 mg/mL, 6 mL Sterile Multi-Dose Vial, Rx Only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC, 27513, NDC 85091-011-06.
- Lots / codes
Lot #: AP-202647, BUD 13-Oct-2026
- Quantity
- 1 vial
- Company
- Apothecary Pharma LLC, Cary, NC
- Distribution
- Nationwide within the United States
- Initiated
- September 24, 2026 · Voluntary: Firm initiated
- Classified
- October 8, 2026
- Reported
- October 14, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.